StockData
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. (EBS) stock

EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3074% below fair value
$5.61−0.20 (-3.44%)

Close on Nov 17, 2026Market cap $287.64MP/E –Yield –

Emergent BioSolutions pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Emergent BioSolutions's pe ratio was 8.8× on Apr 30, 2026, against 12.3× a year earlier. Over the last 5 years it ranged from 3.4× to 787.0×, with a median of 16.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20268.8×−0.7
2025Dec 31, 20259.5×−9.3
2023Jan 31, 202318.8×+2.0
2022Dec 30, 202216.9×+5.8
2021Dec 31, 202111.1×−17.6
2020Dec 31, 202028.7×−742.0
2019Dec 31, 2019770.7×+740.5
2018Dec 31, 201830.2×+4.3
2017Dec 29, 201726.0×−7.2
2016Dec 30, 201633.2×−0.2
2015Dec 31, 201533.3×−23.4
2014Dec 31, 201456.7×+21.4
2013Dec 31, 201335.4×+16.3
2012Dec 31, 201219.1×−9.9
2011Dec 30, 201129.0×+5.3
2010Dec 31, 201023.7×–

More Emergent BioSolutions figures

See a number that looks wrong?